Bacterial populations produce dormant persister cells that are resistant to killing by all antibiotics currently in use, a phenomenon known as multidrug tolerance (MDT). Persisters are phenotypic variants of the wild type and are largely responsible for MDT of biofilms and stationary populations. We recently showed that a hipBA toxin/antitoxin locus is part of the MDT mechanism in Escherichia coli. In an effort to find additional MDT genes, an E. coli expression library was selected for increased survival to ampicillin. A clone with increased persister production was isolated and was found to overexpress the gene for the conserved aerobic sn-glycerol-3-phosphate dehydrogenase GlpD. The GlpD overexpression strain showed increased tolerance to ampicillin and ofloxacin, while a strain with glpD deleted had a decreased level of persisters in the stationary state. This suggests that GlpD is a component of the MDT mechanism. Further genetic studies of mutants affected in pathways involved in sn-glycerol-3-phosphate metabolism have led to the identification of two additional multidrug tolerance loci, glpABC, the anaerobic sn-glycerol-3-phosphate dehydrogenase, and plsB, an snglycerol-3-phosphate acyltransferase.
Persisters are specialized cells that exhibit multidrug tolerance (MDT), an ability to survive killing by antibiotics acting against unrelated targets (8, 20, 29, 38, 44, 47, 48) . Tolerance is mechanistically distinct from resistance, which acts to prevent the antibiotic from inhibiting the target. We have suggested that tolerance results from antibiotic targets being blocked in a benign way by MDT proteins (29) . Bactericidal antibiotics kill not by merely inhibiting a function but also by corrupting the target. For example, ␤-lactam antibiotics inhibit cross-linking of peptidoglycan, causing autolysis, aminoglycosides create toxic misfolded peptides by interrupting translation, and fluoroquinolones inhibit the ligase function of topoisomerase, resulting in DNA strand breaks (39, 41, 46) .
In previous work, we isolated persisters from a population of Escherichia coli lysed with ampicillin and obtained an expression profile of these cells (29) . The profile showed downregulation of proteins involved in energy production and nonessential functions such as flagellar synthesis, suggesting that persisters are dormant cells. The expression profile was also consistent with the finding that persisters formed by a hipA7 mutant mutant strain (an allele conferring high persistence) of E. coli are nongrowing (or slow-growing) cells (4) . The profile pointed to proteins that may be responsible for dormancy: RMF, a stationary-state inhibitor of translation, SulA, an inhibitor of septation, and toxin-antitoxin (TA) module elements RelBE, DinJ, and MazEF (7, 12, 51) . We have shown that expression of RelE, a "toxin" that causes reversible stasis by inhibiting translation, strongly increases tolerance to antibiotics (29) . As with RelE, expression of the putative HipA toxin increased tolerance as well, but unlike RelE, deletion of the hipBA locus caused a sharp, 10-to 100-fold decrease in persister production in stationary-state and biofilm cultures (29) . This suggested that hipA is the first bona fide persister/MDT gene. Deletion of other potential candidates, such as rmf, relE, or mazF, had no discernible phenotype in persister production, possibly due to the high degree of redundancy of these elements. In E. coli there are at least 10 TA modules, and there are Ͼ60 in Mycobacterium tuberculosis (23) . We have suggested that the term "toxin" is a misnomer and that the function of chromosomal TA modules like hipBA is to protect the population from lethal factors by creating a subpopulation of multidrug-tolerant, dormant persister cells.
Persisters are not created in early exponential phase but rise to ϳ1% in a stationary population (28, 44) . This suggests that the major role of persisters is to protect the population from extinction when it is in a nongrowing, surviving mode. The presence of persisters, especially in biofilms protected from the immune system, presents a serious human health problem by creating multidrug-tolerant infections (16, 32) . In Western countries, biofilms are responsible for 65% of all human infections (33) . Finding the mechanism of tolerance will provide an understanding of an important microbial survival strategy and may lead to the development of much-needed antipersister therapies.
In this study, we report the identification of three additional genes involved in MDT: plsB, glpD, and glpABC. PlsB, the glycerol-3-phosphate acetyltransferase, is an essential and conserved persister protein that is a potential target for antipersister therapy.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Bacterial strains and plasmids are listed in Table 1 . Wild-type E. coli K-12 EMG2 (3, 14) was obtained from the E. coli Genetic Stock Center (EGSC 4401) and used as the parental strain. Cells were cultured in Luria-Bertani (LB; 10 g tryptone, 5 g yeast extract, 10 g sodium chloride; Fisher Scientific) medium with aeration at 37°C unless otherwise indicated. When required, the medium was supplemented with antibiotics at the following final concentrations: ampicillin (Sigma), 100 g/ml; chloramphenicol (Sigma), 30 to 50 g/ml; kanamycin (Fisher), 50 g/ml; ofloxacin (Sigma), 5 g/ml; and ciprofloxacin (Sigma), 5 g/ml.
Recombinant DNA procedures. PCR amplification was performed using Taq DNA polymerase (New England BioLabs [NEB]) except when PCR products were used for cloning. In the latter case, Pfu DNA polymerase (Stratagene) was used. Sequencing was performed by the Forsyth sequencing facility, Boston, MA, or Seqwright, Houston, TX.
Expression library construction. Genomic DNA from EMG2 was purified using Promega's Wizard genomic DNA purification kit and partially digested with Sau3aI. The digest was then separated on an agarose gel, and the region corresponding to 3-to 10-kb fragments was excised. Fragments were ligated into the BamHI (NEB) site of pACYC184 (NEB E4152S). Chemically competent JM109 cells (Stratagene) were transformed with the genomic library, plated on LB agar with 50 g/ml chloramphenicol, and cultured overnight at 37°C. Approximately 4,500 of the resulting colonies were lifted into 4 ml LB broth with 8% dimethyl sulfoxide and frozen at Ϫ80°C in 50-l aliquots.
Selection procedure and clone validation. The genomic library was cultured in LB medium to exponential phase and selected for survival upon exposure to ampicillin (100 g/ml). Survival was compared to the negative control containing an empty vector in strain KLE401. A KLE401 culture spiked with a highpersistence hipA7 mutant strain, HM22, at a 1:10,000 ratio served as a positive control for the selection procedure. Cultures of HM22, KLE401, or the genomic library were first grown for 18 h to stationary phase. For the first round of selection, the stationary-phase negative control culture was diluted 1:100 into LB medium and the genomic library was diluted 1:100 in 100 ml LB with 75 g/ml diaminopimelic acid (no chloramphenicol added) in a 1-liter flask and grown for 3 h. The positive control contained KLE401 diluted 1:100 and HM22 diluted 1:10,000 and was grown under identical conditions. After 3 hours the cultures were sampled and initial cell density was determined by diluting and plating. Ampicillin was then added to a final concentration of 100 g/ml. After 3 h of exposure to ampicillin, the cells were centrifuged at 10,000 ϫ g for 10 min at 10°C. The pellet was resuspended in 12.5 ml LB, sampled for surviving cells, and grown overnight in a 125-ml flask. The sample of surviving cells was plated on LB, and the positive control was plated on LB with chloramphenicol. Onemilliliter samples of each culture were frozen in 20% glycerol after each round of selection. Each subsequent round of selection was initiated by diluting the previously selected overnight culture 1:100 in 100 ml LB followed by 3 h of growth, killing by ampicillin, and recovery procedures. After the fourth sequential selection, individual clones from the library were picked and grown for plasmid isolation. The plasmids were transformed into a clean JM109 background and tested for high-persistence phenotype under conditions corresponding to a single selection round. Unique high-persistence clones were identified by restriction digestion using SspI (NEB). Unique clones were sequenced using primers to plasmid pACYC184: LpACYC184 (5Ј-GTCACTATGGCGTGCTG CTA-3Ј) and RpACYC184 (5Ј-GGTGATGTCGGCGATATAGG-3Ј). Construction of a GlpD overexpression vector and glpD mutagenesis. glpD was cloned into the multicloning site of pBAD33 (13) to create pBADglpD. The gene was amplified from K-12 genomic DNA using primers xbaIglpD (5Ј-GCTCTAG AGGAGTGAAACGATGGAAACCAAAGATCTGATTGT-3Ј with XbaI site [italics], Shine-Dalgarno [underlined] , and start codon [bold] ) and sphIglpD (5Ј-AAAAGCATGCAATTTACGACGCCAGCGATA-3Ј). This vector was transformed into EMG2 to create strain KLE414. A glpD point mutant was created by mutating glycine 15 to an arginine in the flavin adenine dinucleotide (FAD) binding site. The codon was mutated from GGT to AGG using primers g43a/t45gglpD (5Ј-GGGCGGCATCAATAGGGCTGGTATCGCGGC-3Ј) and ASg43a/t45glpD (5Ј-GCCGCGATACCAGCCCTATTGATGCCGCCC-3Ј). The mutagenesis was done using Stratagene's QuikChange site-directed mutagenesis kit, and the resulting plasmid, pBAD3-2, was transformed into EMG2, creating strain KLE443. The resulting mutant's sequence was confirmed.
L-␣-Glycerophosphate dehydrogenase assay. L-␣-Glycerophosphate dehydrogenase activity was measured in crude cell extracts using a procedure adapted from Lin et al. (34) . Stationary cultures were diluted 1:1,000 in 20 ml LB containing 50 g/ml chloramphenicol and 0.2% arabinose and grown until the cell density reached ϳ2 ϫ 10 7 CFU/ml. The cells were pelleted at 10,000 ϫ g for 10 min at 4°C, washed in 25 ml deionized H 2 O, and resuspended in 0.5 ml 0.1 M Tris-HCl, pH 7.4. The cells were disrupted using an ultrasonic homogenizer (model 150V/T; Biologics, Inc.) with the power set at 40 and pulsed at 30% for 4 min in an ice-H 2 O bath. Glycerophosphate dehydrogenase activity was measured by following reduction of 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT) into formazan absorbing at 550 nm. Five l of freshly prepared crude cell extract was added to 3 ml of the reaction buffer containing 0.01 M KCN, 0.33 mM phenazine methosulfate in phosphate-buffered saline (PBS), pH 7.5, 89 M MTT in 1ϫ PBS, pH 7.5, and 1ϫ PBS, pH 7.5, at 25°C. The reaction was started by adding 0.1 ml of 1 M DL-␣-glycerophosphate. The total protein concentration of the samples was determined using the Pierce Biotechnology Micro BCA protein assay reagent kit.
G3P determination. Glycerol-3-phosphate (G3P) was determined by a procedure adapted from references 25 and 42. One milliliter of stationary-phase cells (or 10 ml of a 1:10 dilution of stationary-phase cultures in fresh LB medium) was washed with the same volume of room temperature PBS, pH 7, and resuspended in 60 l ice-cold water. Ten microliters of this suspension was mixed with 40 l water and heated for 15 min at 95°C to quantify the protein concentration using the Bradford reagent (Sigma) following the manufacturer's instructions. Four microliters of aldehyde-free formic acid (Fisher) was added to the remainder of the cell suspension (final concentration, 1.4 M) and then incubated on ice for 1 h. The suspension was centrifuged, and the supernatant was moved to a clean tube and neutralized with 30 l of 5 M K 2 CO 3 (final concentration, 1.8 M). The enzymatic assay for detecting glycerol-3-phosphate was based on the conversion of NAD to NADH by glycerol-3-phosphate dehydrogenase (Fisher) by measuring NADH fluorescence at 445 nm (excitation, 340 nm) with a Molecular Dynamics fluorescent plate reader. Five microliters of cell lysate was added to 143.5 l of a glycine-hydrazine buffer (1 M glycine, 0.4 M hydrazine sulfate, 1 M NaOH, 5 mM disodium-EDTA) containing also 2 mg/ml ␤-NAD and was blanked after a 10-min incubation at 37°C. Then, 1.5 l glycerol-3-phosphate dehydrogenase (0.1 mg/ml final concentration; Fisher) was added and the measurement was taken at 445 nm (excitation, 340 nm) after a 15-min incubation at 37°C. A standard curve was prepared using glycerol-3-phosphate (Fisher). The concentration of glycerol-3-phosphate was expressed per total protein concentration of each sample.
MIC assay. The MIC of each antibiotic was determined by the standard NCCLS broth microdilution method (2).
Multidrug tolerance assay. Persistence was measured by determining survival upon exposure upon exposure to 100 g/ml ampicillin, 5 g/ml ofloxacin, or 5 g/ml ciprofloxacin in exponential-and stationary-phase cultures.
Stationary-phase cultures were produced by inoculating 3 ml LB with a 1-l aliquot of frozen stock into 17-by 100-mm polypropylene tubes and growth for at least 16 h. The initial cell concentration was determined by sampling 10 l and serially diluting and plating on LB agar. Cell survival was tested by diluting the culture 1:10 into fresh medium containing antibiotics and sampling after 6 h of shaking at 37°C.
Late-exponential-phase cultures were produced by first diluting a stationaryphase culture 1:1,000 in LB medium (12.5 l in 125 ml). These cells were then shaken with aeration at 37°C for 5 h. The initial cell concentration was determined by sampling 10 l and serially diluting and plating on LB agar. Onemilliliter aliquots of the late-exponential-phase cells were exposed to antibiotics for 3 h. After 3 h, samples were removed, serially diluted, and plated on LB agar.
Strain construction. The strains were constructed as previously described by homologous recombination using a PCR product that deleted the entire gene and stably replaced it with a selectable marker (18) . Primers were designed with 50 bp upstream and downstream of the gene plus the complementary sequence for amplification of the kanamycin resistance cassette of pKD13. Primers used for creating and verifying knockouts will be made available on request. Some deletions were transduced from other backgrounds into EMG2 using P1 (Table  1) .
RESULTS
Selecting a genomic library for persister genes. A genomic library was prepared by cloning partially digested DNA from strain EMG2 into pACYC184 and transformation into E. coli JM109. For selection, cells were cultured in LB medium to exponential phase and ampicillin was added at 100 g/ml. At this concentration, ampicillin effectively lyses regular cells and only persisters survive (6, 29) . E. coli does not form mutants resistant to such a high dose of ampicillin, ensuring that any surviving cells are persisters. An HM22 hipA7 strain that produces 1,000-fold-more persisters (1%) in exponential phase than the wild type was used as a control to probe the selection procedure. hipA7 cells were mixed with the wild type at a 1:10,000 ratio and subjected to repeated rounds of selection by exposing cells to ampicillin and then culturing surviving cells. Plating on LB agar and LB agar with tetracycline allowed for separately counting colonies of the KLE401 and hipA7 cells, correspondingly. After three cycles, the surviving cells were HM22 (no chloramphenicol-resistant KLE401 cells were detected), showing that this method can effectively select for cells with an increased probability of persister formation (Fig. 1) .
Cells from the recombinant library were subjected to a similar selection, and after four rounds of enrichment, 4.0 ϫ 10 6 CFU/ml out of the 2.4 ϫ 10 7 CFU/ml of logarithmically growing culture of library clones survived, while only 5 ϫ 10 5 CFU/ml of 3.2 ϫ 10 7 CFU/ml of the negative control survived. After normalization to the initial cell concentration of the negative control, the survival of the library was 37 times longer than the control with an empty vector (Fig. 1) .
Plasmids prepared from six of the clones present after the fourth selection were retransformed into wild-type cells, and exponential-phase cells were tested for tolerance to ampicillin and ofloxacin in a dose-response experiment (data not shown). Four of the six clones survived better than the wild-type control. Clone 4-1 showed the strongest increase in tolerance and was examined further.
Analysis of GlpD involvement in persister formation. The recombinant plasmid of clone 4-1 had a 6.3-kb insert in the pACYC184 vector. Sequencing of the insert showed that it contained two genes, glpD and yzgL. GlpD is an inner membrane-associated sn-glycerol-3-phosphate dehydrogenase, and yzgL is a conserved hypothetical protein (45) . The glpD gene was PCR amplified, cloned into the pBAD33 vector under the arabinose promoter, and transformed into wild-type KLE401 cells. Cells carrying the pBADglpD plasmid expressing glpD showed increased tolerance to ampicillin and ciprofloxacin in late exponential phase (Fig. 2) .
We have previously shown that persisters are not formed in the early exponential phase of E. coli growth but instead increase in mid-to late-exponential-phase growing cells (28) . In agreement with this finding, a time course experiment showed the persister level in GlpD-expressing cells increased faster than the wild type carrying the control vector (data not shown), and in late exponential phase (5 h of growth), this strain formed 10 times more persisters (1.6 ϫ 10 7 CFU) than the wild type carrying the control vector (1.3 ϫ 10 6 CFU) (Fig. 2) . The persister level of the GlpD-producing strain was four times higher (an average of 3.7 ϫ 10 5 CFU) when tested with ofloxacin, an inhibitor of DNA gyrase/topoisomerase that is capable of killing nongrowing cells, compared to the wild type carrying the control vector (an average of 9.3 ϫ 10 4 CFU) (Fig. 2) . The survival rate observed in the experiment is different from that in the original selection. We believe this is a result of different culture conditions as well as differences in time of exposure to the antibiotics. Variations in persister levels have also been observed by others studying the persistence phenomenon (30, 48) .
Cells overexpressing glpD had a similar growth rate compared to wild type, and their MICs to ampicillin and ofloxacin were unchanged (6.25 g/ml and 0.1 g/ml, respectively). This confirms that while expression of GlpD increases the frequency of persisters, it does not affect resistance.
To test persister formation in cells lacking GlpD, a precise glpD deletion was created by allelic replacement, producing strain KLE416. This strain was unable to grow on a medium containing glycerol as a sole carbon source and grew on glucose minimal medium, confirming the ⌬glpD phenotype (34) . Exponential-phase cells of KLE416 did not show an apparent change in the level of persisters. However, the persister level in KLE416 decreased by 20-fold in undiluted (data not shown) and by 55-fold in diluted stationary state compared to the wild type (Fig. 3) . This is similar to our previous observations with ⌬hipA cells, which have a decreased level of persisters but only in stationary state (29) . Note that the level of persisters at FIG. 1. Selection of an E. coli overexpression clone library for increased persister production. Ampicillin (100 g/ml) was added to exponential-phase cells in a growth medium, and after 3 h of incubation surviving cells were collected, washed, and regrown for a subsequent round of selection. The percent survival is normalized to the amount of killing of the negative control on each day. Black bars, negative control (KLE401); white bars, positive control (KLE401) and high-persistence mutant HM22 added at 1:10,000 before round 1; hatched bars, expression library. The level of persisters for the positive control was not determined on day 4; this is indicated by a star .   FIG. 2 . Levels of persistence to ampicillin or ofloxacin in late exponential phase. Cells were diluted 1:1,000 and induced with 0.2% arabinose at time zero. After 5 h; samples were removed and tested for their multidrug tolerance to 100 g/ml ampicillin or 5 g/ml ofloxacin. The starting cell number for each was 1 ϫ 10 9 CFU/ml. Black bars, wild-type control (KLE421); white bars, overexpression of GlpD (KLE414); hatched bars, overexpression of inactive GlpD (KLE443). These data are the averages of three independent experiments, and the error bars correspond to the standard deviations of the means. FIG. 3 . Survival of mutants affected in putative persister genes. Cells were grown to stationary phase and diluted 1:10 in fresh medium (final concentration, ϳ3 ϫ 10 8 CFU/ml) containing 5 g/ml ciprofloxacin. After 6 h of exposure, cells were washed, diluted, and spot plated. The wild type is EMG2, and all mutations were made in this background. These data are the averages of the log percent survival of at least three independent experiments, and the error bars correspond to the standard deviations of the means.
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to 10 Ϫ4 in early exponential phase), indicating that they have a significantly more important role in a nongrowing population. Knocking out glpD eliminates the bulk of stationary-state persisters, suggesting that glpD is essential in MDT cells.
It was important to learn whether the effect of GlpD on persister formation was due to its catalytic activity or, rather, to the physical presence of this protein. Site-directed mutagenesis was used to replace a conserved arginine in the glycine-rich FAD-binding region with glycine. The complete loss of glycerol-3-phosphate dehydrogenase activity in the mutant was confirmed using a colorimetric assay for G3P (data not shown). The strain carrying plasmid pBAD3-2 with the mutant glpD gene had the same level of persisters as the wild type carrying the control vector in exponential phase (data not shown) and in late exponential phase (an average of 1.3 ϫ 10 5 CFU versus 0.8 ϫ 10 5 CFU) (Fig. 2) . This result links persistence to the G3P dehydrogenase activity of GlpD.
To further analyze the role of GlpD in persister formation, we considered the role of GlpD in E. coli metabolism (Fig. 4) . GlpD and its paralog, GlpA, are involved in the enzymatic conversion of dihydroxyacetone phosphate (DHAP) into G3P (15, 26) . It seemed logical to test both for their roles in persister formation. Under aerobic conditions, ⌬glpABC (KLE418) had a lower persister level than the wild type but it was still higher than ⌬glpD (KLE416) (Fig. 3) . The effect of the loss of glpABC on persister formation was not large, and we hesitate to draw far-reaching conclusions from this. However, the behavior of ⌬glpD and ⌬glpABC, coupled with the absence of a phenotype in a strain overexpressing a nonfunctional GlpD, implicates dehydrogenation of G3P in persister formation.
Some strains tested for their survival were created using cotransduction with a selectable marker. malT::Tn10 and malF::Tn10 were both used in the experiments detailed in Fig.  3 . Note that these mutations alone had no effect on the level of persistence when compared to the wild type. However, both malT::Tn10 and malF::Tn10 mutations somewhat exaggerated the effect of a glpD mutation in a wild-type background. This result points to the possible involvement of other metabolites, like maltose, in the persistence phenomenon.
Another potential player in persister formation is GpsA, an enzyme that preferentially catalyzes the reaction from DHAP to G3P (Fig. 4) (17, 26) . However, our inability to construct a strain with gpsA deleted suggests it is an essential protein.
G3P has a prominent position in E. coli metabolism and is linked to several pathways that could potentially affect persister formation. We were particularly interested in the methylglyoxal (MG) pathway, which produces MG, an intermediate that causes cell stasis (1) . MG synthesis is a glycolytic bypass that leads to pyruvate via DHAP and MG (Fig. 4) (1, 11, 22, 36) . DHAP is the product of GlpD-catalyzed dehydrogenation of G3P, and one would expect that an increase in DHAP would lead to an increase in MG, which could in turn produce dormancy. However, persister levels were not affected in strains with a deletion of mgsA (KLE4481), the enzyme converting DHAP into MG (data not shown), nor were they affected in a strain with a deletion of gloA (KLE449), an enzyme that catalyzes the detoxification of MG to pyruvate (36) (data not shown). These results indicate that MG is not involved in persister formation.
Deletion of glpD leads to at least two important changes: it abolishes the conversion of G3P to DHAP under aerobic conditions, resulting in an increase in the intracellular concentration of G3P, and this in turn leads to derepression of the glp regulon through the binding of G3P to the GlpR repressor (52) . We sought to assess these two effects (high G3P concentration and induction of glp regulon) of the glpD mutation separately. We reasoned that we could eliminate the derepression of the glp regulon by taking advantage of an allele of the glpR repressor gene, glpR12, that codes for a repressor that is insensitive to G3P concentration (52) . In this mutant strain, the glp regulon cannot be derepressed. We compared persister levels in control strains and in a ⌬glpD glpR12 double mutant (MV1715 in the wild-type background, MV1718 in the KLE416 background), as well as a ⌬glpD⌬glpR double mutant (MV1703 in the wild-type background, MV1723 in the KLE416 background). We observed that each glpR mutation alone did not affect multidrug tolerance compared to the isogenic wild type (Fig. 3) . As expected, a double deletion of glpD and glpR (where high G3P cannot further derepress the constitutive expression of the regulon) had tolerance levels similar to the ⌬glpD background. On the other hand, when the ⌬glpD mutant was combined with a glpR12 noninducible allele, it lost its phenotype and had wild-type levels of persistence (Fig. 3) . These results show that both the induction of the glp regulon and high levels of G3P are needed for the observed effect on persistence. G3P is the precursor of the backbone of phospholipid biosynthesis (Fig. 4) (26) . It seemed possible that depletion of G3P would cause an inhibition of phospholipid biosynthesis and result in a larger subpopulation of multidrug-tolerant, dormant cells. The PlsB enzyme that uses G3P to produce 1-acyl-G3P is essential, and we could not analyze the behavior of a null mutant. However, a strain with a mutant PlsB enzyme with a higher K m has been described (plsB26), and we used it to examine persister formation (24) . The plsB26 strain grew normally and showed the same MICs to ampicillin and ofloxacin as an isogenic wild-type control (data not shown). Interestingly, the plsB26 strain produced considerably fewer persisters than either the wild type or the ⌬glpD strain (Fig. 3) . This result was unexpected, as a decrease in PlsB function would diminish the rate of phospholipid synthesis, which could result in dormancy and increase the level of persisters.
Testing of additional members of the glp regulon and components of metabolism connected to G3P showed no effect on persister formation (data not shown). Thus, strains with deletion of tpiA (40) , mdoB (27) , mdoH (27) , glpQ (31) , ugpQ (31), gldA (5, 50) , glpK (35) , glpF (35) , glpX (19) , and glpT (35) had no phenotype when their survival in the presence of ofloxacin was tested in the stationary state. This mutational analysis essentially completes the known pathways linked to GlpD and G3P. Intracellular G3P concentration. It seemed interesting to learn whether the intracellular level of G3P correlated with persister production. G3P concentration was therefore measured in a variety of strains described in the previous sections.
G3P concentration in stationary phase was low in the wild type and, as expected, much higher (50-fold) in the glpD strain (Fig. 5) . A mutation in glpD increased the G3P level in all backgrounds except when combined with glpR12, the noninducible GlpR repressor (Fig. 5) . In a glpR12 background, glpD itself cannot be induced above its basal level and therefore does not dehydrogenate a significant amount of G3P. Hence, the G3P level is higher in a glpR12 background than in the wild type, but not as high as in ⌬glpD. G3P is a substrate of PlsB, but the decrease in PlsB activity (plsB26 allele) did not lead to an increase in G3P concentration (Fig. 5 ). This result shows that the partially functional plsB26 allele was not affecting persistence by elevating G3P.
Persisters resuscitate from their dormant state when a stationary culture is inoculated into fresh medium. We therefore wanted to know how G3P levels change under these conditions. Upon inoculation of stationary-phase cells into fresh LB medium, the G3P level of both wild-type and ⌬glpD strains increased significantly (Fig. 6 ). In the wild type and in the ⌬glpD strain, the G3P concentration peaked at 20 min after the reinoculation. This transient increase was dramatic in the wild type, where it dropped to the basal level by 40 min. The decrease in ⌬glpD cells was much slower. This result is consistent with high G3P levels correlating with the low persister frequency typically observed in exponential phase and in the ⌬glpD mutant. When resuscitated, a cell would become as sensitive as the bulk of the population. This possibility is supported by our observation of wild-type cells undergoing a spike in G3P concentration when diluted into fresh medium (Fig. 6) . glpD is part of the glp regulon, consisting of five operons, all controlled by the GlpR repressor. Deletion of glpD leads to an increase in G3P, the inducer of the regulon, which in turn derepresses all glp operons through G3P binding to GlpR. In order to separate these two effects of glpD mutation (G3P increase and glp regulon derepression), we constructed strains with G3P-insensitive GlpR (the glp regulon cannot be induced) and with glpR deleted (constitutive expression of the glp regulon). While inactivation of glpD reduced persistence by the same amount in wild-type and ⌬glpR backgrounds, it had no effect when combined with a noninducible glpR allele. This suggests that derepression of the glp regulon is essential for the observed effect of the ⌬glpD mutation. However, constitutive expression of the glp regulon alone is not sufficient because the deletion of glpR does not lead to the same drop in persistence as does deletion of glpD (Fig. 3) . The effect of glpD therefore is the combination of both high intracellular G3P levels and the derepression of GlpR-regulated genes.
We considered additional components linked to G3P or the Glp regulon for a possible role in persister formation. Deletions of tpiA (40) , mdoB (27) , mdoH (27) , glpQ (31) , ugpQ (31), gldA (5, 50) , glpK (35) , glpF (35) , glpX (19) , and glpT (35) had no effect on persister formation (Fig. 4) , with one exception-a mutant attenuated in an essential plsB gene had a considerably decreased level of persister formation. The plsB mutant had a low level of G3P, similar to the wild type. We suggest, therefore, that the PlsB effect on persistence is downstream of G3P.
In conclusion, we identified three possible components affecting persister formation: G3P level, the glp regulon, and PlsB. The exact relationship between these components is currently under investigation.
